SWP
CALA

Stratos Wealth Partners’s Calithera Biosciences, Inc CALA Stock Holding History

Stratos Wealth Partners’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-86
Closed -$9K – 2734
2018
Q3 		$9K Buy
+86
New +$8.19K ﹤0.01% 2250
2018
Q2 		– Sell
-36
Closed -$5K – 2822
2018
Q1 		$5K Buy
36
+1
+3% +$156 ﹤0.01% 2633
2017
Q4 		$6K Buy
+35
New +$8.96K ﹤0.01% 2360

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stratos Wealth Partners's CALA Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Calithera Biosciences, Inc (CALA) in Q4 2018, closing a stake of 86 shares — an estimated $9K sold.

Stratos Wealth Partners first reported a position in CALA in Q4 2017 and held it in 3 quarters. The position peaked at $9K in Q3 2018. 77 funds tracked by Wall St. Rank hold CALA as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Calithera Biosciences, Inc position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 86 Calithera Biosciences, Inc shares in Q4 2018, an estimated $9K.
  • Stratos Wealth Partners first reported a position in Calithera Biosciences, Inc in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's Calithera Biosciences, Inc position peaked at $9K in Q3 2018.
  • 77 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.